Role of apoptosis in the pathogenesis of acute renal failure

Renal tubular cells die by apoptosis as well as necrosis in experimental models of ischemic and toxic acute renal failure as well as in humans with acute tubular necrosis. It is not yet possible, however, to determine the relative contribution of these two forms of cell death to loss of renal tubular cells in acute tubular necrosis. The beneficial effect of administering growth factors to animals with acute tubular necrosis is probably related to the potent antiapoptotic (survival) effects of growth factors as well as to their proliferative effects. Rapamycin inhibits both of these effects of growth factors and delays the recovery of renal function after acute tubular necrosis by inhibiting renal tubular cell regeneration and by increasing renal tubular cell loss by apoptosis. The administration of caspase inhibitors ameliorates ischemia-reperfusion injury in multiple organs including the kidney. However, the extent to which this protective effect of caspase inhibition is caused by reduced intrarenal inflammation, or by amelioration of renal tubular cell loss due to apoptosis, remains uncertain. In addition to caspase inhibition, the apoptotic pathway offers many potential targets for therapeutic interventions to prevent renal tubular cell apoptosis.

[1]  V. Fadok,et al.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. , 2002, The Journal of clinical investigation.

[2]  P. Dagher,et al.  Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. , 2001, The Journal of clinical investigation.

[3]  Sudhir V. Shah,et al.  Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. , 2001, Kidney international.

[4]  Philippe P Roux,et al.  Raf-MEK-Erk Cascade in Anoikis Is Controlled by Rac1 and Cdc42 via Akt , 2001, Molecular and Cellular Biology.

[5]  R. Valeri,et al.  Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. , 2001, American journal of physiology. Renal physiology.

[6]  G. Filippatos,et al.  Regulation of apoptosis by vasoactive peptides. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[7]  A. Vijayan,et al.  Hepatocyte growth factor inhibits apoptosis after ischemic renal injury in rats. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  D. Cha,et al.  alpha-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  Marcel Leist,et al.  Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.

[10]  T. Unger,et al.  Angiotensin and its AT2 receptor: new insights into an old system , 2001, Regulatory Peptides.

[11]  K. Matsumoto,et al.  Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. , 2001, Kidney international.

[12]  M. Lucia,et al.  Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. , 2001, The Journal of clinical investigation.

[13]  W. Buurman,et al.  APOPTOSIS AND CHEMOKINE INDUCTION AFTER RENAL ISCHEMIA-REPERFUSION1 , 2001, Transplantation.

[14]  Ulf R. Rapp,et al.  Apoptosis Suppression by Raf-1 and MEK1 Requires MEK- and Phosphatidylinositol 3-Kinase-Dependent Signals , 2001, Molecular and Cellular Biology.

[15]  P. Vandenabeele,et al.  ACTIVATED CASPASE-1 IS NOT A CENTRAL MEDIATOR OF INFLAMMATION IN THE COURSE OF ISCHEMIA-REPERFUSION1 , 2001, Transplantation.

[16]  B. Szende,et al.  RENAL TUBULAR CELL NECROSIS AND APOPTOSIS IN TRANSPLANTED KIDNEYS , 2001, Cell biology international.

[17]  T. Unger,et al.  Angiotensin II type 2 receptors: signalling and pathophysiological role , 2001, Current opinion in nephrology and hypertension.

[18]  A. Harken,et al.  Differential cellular immunolocalization of renal tumour necrosis factor‐α production during ischaemia versus endotoxaemia , 2001, Immunology.

[19]  K. Meldrum,et al.  p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. , 2001, American journal of physiology. Cell physiology.

[20]  L. Racusen,et al.  Role of the renal biopsy in acute renal failure. , 2001, Contributions to nephrology.

[21]  S. Frisch,et al.  Anoikis mechanisms. , 2001, Current opinion in cell biology.

[22]  K. Burns,et al.  Angiotensin II AT(2) receptors inhibit growth responses in proximal tubule cells. , 2001, American journal of physiology. Renal physiology.

[23]  M. Cooper,et al.  Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. , 2000, Kidney international.

[24]  L. Boscá,et al.  Potentiation by nitric oxide of cyclosporin A and FK506-induced apoptosis in renal proximal tubule cells. , 2000, Journal of the American Society of Nephrology : JASN.

[25]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[26]  D. Nicholson,et al.  From bench to clinic with apoptosis-based therapeutic agents , 2000, Nature.

[27]  Rachel L. Allen,et al.  Defying death after DNA damage , 2000, Nature.

[28]  John Savill,et al.  Corpse clearance defines the meaning of cell death , 2000, Nature.

[29]  M. Hengartner The biochemistry of apoptosis , 2000, Nature.

[30]  Junying Yuan,et al.  Apoptosis in the nervous system , 2000, Nature.

[31]  R. Harris,et al.  Oxidant Stress Activates AP-1 and Heparin-Binding Epidermal Growth Factor-Like Growth Factor Transcription in Renal Epithelial Cells , 2000, Nephron Experimental Nephrology.

[32]  P. Dagher Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools. , 2000, American journal of physiology. Cell physiology.

[33]  R. Schrier,et al.  Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. , 2000, American journal of physiology. Renal physiology.

[34]  B. van de Water,et al.  Cleavage of the Actin-capping Protein α-Adducin at Asp-Asp-Ser-Asp633-Ala by Caspase-3 Is Preceded by Its Phosphorylation on Serine 726 in Cisplatin-induced Apoptosis of Renal Epithelial Cells* , 2000, The Journal of Biological Chemistry.

[35]  A. Ortiz,et al.  Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. , 2000, Journal of the American Society of Nephrology : JASN.

[36]  W. Lieberthal,et al.  Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. , 2000, American journal of physiology. Renal physiology.

[37]  E. Clementi,et al.  Inhibition of Caspase-1-Like Activity by Ac-Tyr-Val-Ala-Asp-Chloromethyl Ketone Induces Long-Lasting Neuroprotection in Cerebral Ischemia through Apoptosis Reduction and Decrease of Proinflammatory Cytokines , 2000, The Journal of Neuroscience.

[38]  D. Power,et al.  Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury. , 2000, Kidney international.

[39]  D. Power,et al.  Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. , 2000, American journal of physiology. Renal physiology.

[40]  J. Adams,et al.  Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7 Inhibit Apoptosis and Maintain Cell Functionality* , 2000, The Journal of Biological Chemistry.

[41]  W. Lieberthal,et al.  Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism. , 2000, American journal of physiology. Renal physiology.

[42]  G. Baxter,et al.  Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury , 2000, British journal of pharmacology.

[43]  L. Truong,et al.  Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. , 2000, American journal of physiology. Renal physiology.

[44]  M. Moskowitz,et al.  Dual Role of Caspase-11 in Mediating Activation of Caspase-1 and Caspase-3 under Pathological Conditions , 2000, The Journal of cell biology.

[45]  A. Hishida,et al.  Role of apoptosis in uranyl acetate-induced acute renal failure and acquired resistance to uranyl acetate. , 2000, Kidney international.

[46]  A. Ortiz,et al.  Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. , 2000, Kidney international.

[47]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[48]  A. Strasser,et al.  Apoptosis signaling. , 2000, Annual review of biochemistry.

[49]  W. Sellers,et al.  Apoptosis and cancer drug targeting. , 1999, The Journal of clinical investigation.

[50]  J. Stevens,et al.  The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cells , 1999, Oncogene.

[51]  A. Lau,et al.  Apoptosis induced by cisplatin nephrotoxic injury. , 1999, Kidney international.

[52]  Z. Endre,et al.  Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. , 1999, Kidney international.

[53]  Youhua Liu Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. , 1999, American journal of physiology. Renal physiology.

[54]  R. Schrier,et al.  Role of caspases in hypoxia-induced necrosis of rat renal proximal tubules. , 1999, Journal of the American Society of Nephrology : JASN.

[55]  P. Vandenabeele,et al.  Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. , 1999, The Journal of clinical investigation.

[56]  M. del Río,et al.  Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. , 1999, American journal of physiology. Renal physiology.

[57]  R. Kinscherf,et al.  Modulating apoptosis: current applications and prospects for future drug development. , 1999, Current medicinal chemistry.

[58]  Julian Downward,et al.  Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell–matrix and cell–cell interaction , 1999, Current Biology.

[59]  Junying Yuan,et al.  Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling , 1999, Cell.

[60]  P. Auberger,et al.  A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  N. Thornberry,et al.  Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors* , 1998, The Journal of Biological Chemistry.

[62]  W. Lieberthal,et al.  Necrosis and apoptosis in acute renal failure. , 1998, Seminars in nephrology.

[63]  T. Unger,et al.  Physiological and pharmacological implications of AT1 versus AT2 receptors. , 1998, Kidney international. Supplement.

[64]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[65]  L. Dworkin,et al.  Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. , 1998, Biochemical and biophysical research communications.

[66]  Y. Nakanishi,et al.  Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas. , 1998, Journal of the American Society of Nephrology : JASN.

[67]  J. Megyesi,et al.  Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. , 1998, The Journal of clinical investigation.

[68]  V. Fadok,et al.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.

[69]  J. Megyesi,et al.  Induction of p 21 WAF 1 / CIP 1 / SDI 1 in Kidney Tubule Cells Affects the Course of Cisplatin-induced Acute Renal Failure , 1998 .

[70]  W. Lieberthal,et al.  Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells. , 1997, American journal of physiology. Renal physiology.

[71]  M. Brezis,et al.  Frequent apoptosis in human kidneys after acute renal hypoperfusion. , 1997, Experimental nephrology.

[72]  H. Endou,et al.  Cisplatin-induced apoptosis of immortalized mouse proximal tubule cells is mediated by interleukin-1β converting enzyme (ICE) family of proteases but inhibited by overexpression of Bcl-2 , 1997, Archives of Toxicology.

[73]  W. Lieberthal,et al.  Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. , 1996, The American journal of physiology.

[74]  B. Kraupp,et al.  In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note , 1995, Hepatology.

[75]  M. Su,et al.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[76]  R. Kamen,et al.  Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[77]  M. Paskind,et al.  Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. , 1995, Cell.

[78]  W. Bursch,et al.  Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. , 1990, Carcinogenesis.

[79]  G. D'Amico,et al.  The role of renal biopsy in acute renal failure. , 1987, Advances in experimental medicine and biology.

[80]  C. Gornick,et al.  Recovery from acute renal failure. , 1981, Clinical and experimental dialysis and apheresis.